Cartas al editorhttps://hdl.handle.net/20.500.12805/44892026-11-10T20:28:52Z2026-11-10T20:28:52ZA fatal case of triple coinfection: COVID-19, HIV and TuberculosisOrtiz-Martínez, Y.Mogollón-Vargas, J.M.López-Rodríguez, M.Rodriguez-Morales, A.J.https://hdl.handle.net/20.500.12805/48132025-10-31T18:32:55Z2021-01-01T00:00:00ZA fatal case of triple coinfection: COVID-19, HIV and Tuberculosis
Ortiz-Martínez, Y.; Mogollón-Vargas, J.M.; López-Rodríguez, M.; Rodriguez-Morales, A.J.
As the Coronavirus Disease 2019 (COVID-19) pandemic spreads, there is a concern regarding its clinical and epidemiological implications of bacterial, fungal and viral coinfections in patients with COVID-19 [1]. Particularly, the coinfection of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) and Mycobacterium tuberculosis (MTB) in patients with the Human Immunodeficiency Virus (HIV) infection remains a matter of concern, and the results and clinical course have not been thoroughly studied. Here, we present one case of triple coinfection (HIV/MTB/SARS-CoV-2) in a patient from Northeastern Colombia.
2021-01-01T00:00:00ZCOVID-19 infection during the Olympic and Paralympic Games Tokyo 2020Yashio, T.Murayama, A.Kami, M.Ozaki, A.Tanimoto, T.Rodriguez-Morales, A.J.https://hdl.handle.net/20.500.12805/48112025-10-31T18:32:55Z2021-01-01T00:00:00ZCOVID-19 infection during the Olympic and Paralympic Games Tokyo 2020
Yashio, T.; Murayama, A.; Kami, M.; Ozaki, A.; Tanimoto, T.; Rodriguez-Morales, A.J.
Dear Editor,
2021-01-01T00:00:00ZVaccination coverage and preventable diseases in Peru: Reflections on the first diphtheria case in two decades during the midst of COVID-19 pandemicMezones-Holguin, E.Al-kassab-Córdova, A.Maguiña, J.L.Rodriguez-Morales, A.J.https://hdl.handle.net/20.500.12805/48122026-10-24T08:01:37Z2021-01-01T00:00:00ZVaccination coverage and preventable diseases in Peru: Reflections on the first diphtheria case in two decades during the midst of COVID-19 pandemic
Mezones-Holguin, E.; Al-kassab-Córdova, A.; Maguiña, J.L.; Rodriguez-Morales, A.J.
Peru has one of the most comprehensive immunization programs in the Latin-America, financed 100% by public resources under regulation of the Ministry of Health (MINSA). This free-of-charge schedule includes 17 vaccines that protect against around 26 diseases and reaches pregnant women and the elderly, although the primary target population is children under five-years-old.
2021-01-01T00:00:00ZLimited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available dataHashimoto, T.Ozaki, A.Bhandari, D.Sawano, T.Murayama, A.Shrestha, S.Sah, R.Tanimoto, T.Montenegro-Idrogo, J.J.Rodriguez-Morales, A.J.https://hdl.handle.net/20.500.12805/48142026-10-26T08:01:16Z2021-01-01T00:00:00ZLimited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available data
Hashimoto, T.; Ozaki, A.; Bhandari, D.; Sawano, T.; Murayama, A.; Shrestha, S.; Sah, R.; Tanimoto, T.; Montenegro-Idrogo, J.J.; Rodriguez-Morales, A.J.
As of early 2021, the widespread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the emergence of more virulent genetic variants globally, which is more infectious with a high mortality rate [1,2]. Hence, a rapid elucidation of the details of SARS-CoV-2 genetic variants, their infectious capacity, and regional surveys to assess the incidence are crucial to controlling the spread of the virus. In Japan, a country early affected in the pandemic [3,4], a variant of concern 202012/01 was first identified in the airport quarantine station on December 25, 2020. Concerned about the further spread of SARS-CoV-2, the Japanese government declared a second state of emergency from January 8 to March 21, 2021.
2021-01-01T00:00:00Z